Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P33
Within normal range
vs 5Y Ago
-14.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-74.68%
2024-111.45%
2023-62.17%
2022-127.00%
202183.37%
20205.14%
2019-38.37%
2018-67.84%
2017-285.49%
20160.00%